Difference between revisions of "Mefruside"

From Self-sufficiency
Jump to: navigation, search
m (Stub sorting and placement of stub template(s))
 
m (1 revision)
 
(No difference)

Latest revision as of 15:45, 19 September 2010

Mefruside
File:Mefruside.png
Systematic (IUPAC) name
4-chloro-N1-methyl-N1-[(2-methyltetrahydrofuran-2-yl)methyl]benzene-1,3-disulfonamide
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 7195-27-9
ATC code C03BA05 (WHO)
PubChem CID 4047
Chemical data
Formula C13H19ClN2O5S2
Molar mass 382.88 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Mefruside (INN) is a diuretic indicated for the treatment of edema and hypertension.[1]

It was developed by Bayer A.G. and is sold under the tradename Baycaron.

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />



  1. Allen HB, Lee DA (1973). "A general practice assessment of mefruside ('Baycaron') in the treatment of oedema and hypertension". Curr Med Res Opin. 1 (9): 547–53. doi:10.1185/03007997309111720. PMID 4779251.